Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1 Pancreatic Neoplasms 1

Interventions

Fluorouracil 61 Leucovorin 56 Oxaliplatin 51 Capecitabine 42 Irinotecan 29 Bevacizumab 21 Radiotherapy 17 Cetuximab 12 Folfox protocol 11 Chemoradiotherapy 11 Neoadjuvant Therapy 10 Chemotherapy, Adjuvant 9 Surgical Procedures, Operative 6 Drug Therapy 6 XELOX 5 Panitumumab 4 Laparoscopy 4 FOLFOXIRI protocol 4 Transanal Endoscopic Microsurgery 3 Radiation 3 Octreotide 3 IFL protocol 3 Floxuridine 3 Diathermy 3 Celecoxib 3 vatalanib 2 spartalizumab 2 Trinitrotoluene 2 Tegafur 2 Semaxinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Rectal Neoplasms × Chemoradiotherapy, Adjuvant × Clear all

NCT02371304 2020-05-21

TESAR

Amsterdam UMC, location VUmc

Phase 3 Unknown

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡